fatnews.com

Discussion Forums
NEW!

Discussion Forums

Recent Forum Topics
NEW!

Recent Forum Topics
We welcome your comments, experience, expertise and insight on various topics about weight loss in these discussion forums.

STORE

The Store

SEARCH THIS SITE


Advanced Search

SEARCH THE WEB

Google

CONTACT US

  • Contact Us
  • Submit your suggestions to improve this site
  • Submit an article you would like reviewed
  • Suggest a drug, nutrient or diet you would like reviewed
  • TABLES

    BMI Table for adults
    BMI Table defining childhood obesity
    Glycemic Index Tables

    MEMBERS

    Login
    Register

    MAILING LIST

    CATEGORIES

    (Tip: To find articles about a particular subject, either search for a particular word, click "Category View" above, or select the category you are interested in from the list below.)
    5-HTP (5-Hydroxytryptophan)
    Abilify (aripiprazole)
    Acarbose (Precose)
    Accountability
    ACE Inhibitor
    Acetyl-L-Carnitine
    Acomplia (rimonabant)
    Actonel (risedronate)
    Actos (pioglitazone)
    Adiponectin
    Aging
    AIDS
    Air Conditioning
    Alcohol
    Alcoholism
    Alii (orlistat) - (also see Xenical)
    All-you-can-eat
    Allergies, Food and Brain
    Almonds
    Alpha Lipoic Acid
    Aluminum
    Alzhemier's Disease
    Amantadine (Symmetrel)
    Ambien (zolpidem)
    Amino Acids
    Amitriptyline (See Elavil)
    Amphetamines
    Amylase inhibitors (See Starch Blockers)
    Anafranil (clomipramine)
    Angina (chest pain)
    Animal-based diet
    Antibiotics
    Antidepressants
    Antihistamines
    Antipsychotic drugs
    Anxiety
    Arginine
    Arthritis
    Articles by others
    Artificial sweetners (general)
    Aspartic Acid
    Aspirin
    Asthma
    Attention Deficit Hyperactive Disorder -- ADHD
    Autism
    Avandia (rosiglitazone)
    Axokine
    Bariatric Surgery (See Weight Loss Surgery)
    Behavioral Therapy, Cognitive
    Belviq (lorcaserin hydrochloride)
    Benefits of weight loss
    Benzodiazepines
    Beta Blockers
    Binge Eating
    Bioidentical hormones
    Birth Control Pills
    Blacks
    Blood Donation
    Blood Pressure
    Blood Pressure Drugs
    Blood Pressure Drugs INCREASED Death in Older women
    Blood sugar
    BMI not perfect
    BMI Table
    BMI, Healthiest (Healthiest BMI)
    Body Composition
    Bone Fractures
    Bone mass
    Book - Blue Zones
    Book - Cholesterol Myths (by Uffe Ravnskov, MD, PhD)
    Book - Deadly Medicines and Organised Crime (by Prof. Peter Gøtzsche, MD)
    Book - Deadly Psychiatry and Organised Denial (by Prof. Peter Gøtzsche, MD)
    Book - Good Calories, Bad Calories (by Gary Taubes)
    Book - Malignant Medical Myths
    Book - Our Daily Meds
    Book - The Black Swan
    Book - Why We Get Fat (by Gary Taubes)
    Brain Allergies (See Allergies, Food and Brain)
    Breakfast
    Breast-feeding
    Broda Barnes, MD, PhD (thyroid expert)
    Bromocriptine (Ergoset)
    Bulimia
    Bupropion (See Wellbutrin)
    Byetta (exenatide)
    C-reactive protein
    Caffeine
    Calcium
    Calcium Channel Blockers
    Calorie content of food
    Calorie Density of Food
    Calorie Intake
    Calorie intake, Underreporting
    Calorie Restriction
    Cancer
    Cancer screening (Does it do any good?)
    Cancer treatments
    Cancer, Bladder
    Cancer, Bowel
    Cancer, Brain
    Cancer, Breast
    Cancer, Cervical
    Cancer, Colorectal
    Cancer, Endometrial
    Cancer, Gallbadder
    Cancer, Kidney
    Cancer, Leukemia
    Cancer, Liver
    Cancer, Lung
    Cancer, Multiple Myeloma
    Cancer, Non-Hodgkin Lymphoma
    Cancer, Oesophageal
    Cancer, Oesophageal (adenocarcinoma)
    Cancer, others
    Cancer, Ovarian
    Cancer, Pancreatic
    Cancer, Prostate
    Cancer, Stomach (gastric cardia)
    Cannabis (marijuana)
    Caralluma fimbriata
    Carbohydrates
    Carnitine, L- (L-carnitine)
    Carpal tunnel syndrome
    Celexa (citalorpam)
    Cell Phones
    Cereal
    Chelation Therapy, EDTA
    Chemtrails
    Chewing
    Childhood Illnesses
    Childhood neglect and abuse
    Childhood Obesity
    Chitosan
    Chocolate (cocoa)
    Cholesterol
    Cholesterol drugs
    Cholesterol Hypothesis Skeptics
    Cholesterol Myths
    Cholesterol, HDL
    Chromium
    Chronic Fatigue
    Citrus aurantium
    CLA (Conjugated Linoleic Acid)
    Clozaril (clozapine)
    Cobalt
    Cochrane Collaboration
    Codonopsis Eupolyphaga
    Coffee
    Coffee, Decaffeinated
    Cognitive function
    Commercial Weight Loss Programs
    Computer Use
    Conflicts of Interest
    Congestive Heart Failure
    Constipation
    Contrave (Wellbutrin (bupropion) plus naltrexone)
    Copper
    CoQ10 (Coenzyme Q10, ubiquinol, ubiquinone)
    Cortisol (stress hormone)
    Cost of food
    Costs associated with obesity
    Cravings
    Cymbalta (duloxetine)
    Daniel Amen, MD
    Death, Risk of
    Deaths from obesity
    Definitions
    Dental Amalgams (mercury fillings)
    Depo-Provera (depot-medroxyprogesterone acetate)
    Depression
    Desire to Lose Weight
    DHEA
    Diabetes
    Diabetes drugs
    Diagnosed Overweight by a Doctor
    Dialysis
    Diet drug use
    Diet Pills (General Info)
    Diet soda
    Dietary Counseling
    Diethylpropion (Tenuate)
    Dieting (General)
    Dieting, Intermittent
    Dinitrophenol
    Disability
    Discrimination against obesity
    Diuretics
    Diverticulitis
    Doctor - Abram Hoffer, MD, PhD
    Doctor - Boyd Haley, PhD
    Doctor - Dr. Kailash Chand
    Doctor - H. Gilbert Welch, MD (author of Overdiagnosed and Less Medicine, More Health)
    Doctor - Irving Kirsch, PhD
    Doctor - Jason Fung, MD
    Doctor - Joel Kauffman, PhD (author of Malignant Medical Myths)
    Doctor - John Abramson, MD (author of Overdosed America)
    Doctor - Jonathan Wright, MD (pioneer in natural medicine)
    Doctor - Kimber Stanhope, PhD
    Doctor - Malcolm Kendrick, MD author of "The Great Cholesterol Con"
    Doctor - Marcia Angell, MD
    Doctor - Mary Enig, PhD
    Doctor - Michel de Lorgeril, MD
    Doctor - Peter Gøtzsche, MD
    Doctor - Robert Lustig, MD
    Doctor - Suzanne Humphries, MD
    Doctor - Uffe Ravnskov, MD PhD
    Doctor - William Wilson, MD
    Doctor trends
    Don't fall for this
    Dopamine agonists
    Drug company lies
    Drug Company Money
    Drug Company Salesman
    Drug Company Tactics
    Drug-induced Side Effects
    Dry Skin
    Duodenal Switch (weight loss surgery)
    Eating time of day
    Economic Issues and Obesity
    Education
    Eggs
    Elavil (amitriptyline)
    Elderly
    Elderly, risk of obesity
    Empatic (Zonegran plus Wellbutrin)
    Environmental chemicals
    Ephedrine/Ephedra
    Epigenetics
    Erectile Dysfunction
    Escitalopram (Lexapro)
    Estrogen replacement therapy
    Evening Primrose Oil
    Every Other Day Modified Fast
    Excalia
    Exercise
    Exhaustion
    Fast Food
    Fasting, Intermittent
    Fat Cells
    Fat Intake (Dietary Fat)
    Fat loss
    Fat Oxidation
    Fat Replacers
    Fat, Body (Body Fat)
    Fat, Dietary
    FDA (U.S. Food and Drug Administration)
    Fen-Phen
    Fertility (see Pregnancy)
    Fiber (Dietary Fiber)
    Fiber supplements
    Fidgeting
    Fish
    Fish Oil (omega-3 fatty acids)
    Flaxseed
    Food Allergies (See Allergies, Food and Brain)
    Food Cues
    Food Diary
    Food Intake statistics
    Food preferences associated with obesity
    Food Pyramid
    Food Safety
    Food's effect on appetite
    Foods associated with higher and lower body weight
    Foods Associated with Weight Gain
    Forskolin (from the plant Coleus forskohlii)
    Fosamax (alendronate)
    Fructose
    Fruit
    Fucoxanthin
    GABA
    Gallbadder Disease
    Gallstones
    Garlic
    Gastro-esophageal reflux disease
    General Health Checks
    Genes and genetics
    Geodon (ziprasidone)
    Ghrelin
    Ginger
    Ginseng
    GLA (Gamma Linolenic Acid)
    GLA - Gamma Linolenic Acid
    Glucomannan (konjac root)
    Glucophage (metformin)
    Glutamine (amino acid)
    Glycemic Index
    Glycemic Index Tables
    Glycomacropeptide
    GMO foods (genetically modified organisms)
    Grains
    Grapefruit
    Green coffee bean extract
    Green Tea
    Group Therapy
    Growth Hormone
    Guar gum
    Gut Bacteria
    Gwen Olsen
    Habits associated with obesity
    Habits of being lean
    Hair Loss (caused by weight loss)
    Haldol (haloperidol)
    Hawaiian Diet
    HCG (human chorionic gonadotropin)
    Headaches
    Health Insurance
    Health Risks of obesity
    Heart Attack (myocardial infarction)
    Heart Disease
    Heart Disease, Coronary - Skeptics of the Cholesterol Hypothesis
    Heavy metal toxicity
    Herbal formula, Number Ten
    Herbal formula, PM-F2-OB
    Hibiscus tea
    High Carbohydrate Diet
    High-Fructose Corn Syrup
    High-Protein / Low-Carb Diets
    Histamine levels
    History
    Holiday Weight Gain
    Homocysteine
    Hoodia
    Hop extract, isomerized
    Hunger
    Hydralazine
    Hydrogenated vegetable oil (partially hydrogenated oil)
    Hydroxycitrate (HCA)
    Hypoglycemia
    Hypothyroidism, including Type 2 Hypothyroidism
    IGF-1 (insulin-like growth factor-1)
    Income level
    Infections
    Infertility
    Influenza (Flu)
    Injuries
    Insulin
    Insulin sensitivity
    Interview with Patients
    Interview with Stephen Gullo, PhD
    Interviews with Doctors
    Iodine
    Jenny Craig Weight Loss Program
    Joan Mathews Larson, PhD
    John Ioannidis
    Just for Fun
    Kidney Disease
    Kidney stones
    Kidney Stones
    Konjac root (See glucomannan)
    Krill Oil
    Lap Band Surgery
    Lead (heavy metal toxicity)
    Lean, things associated with being
    Legumes
    Leptin
    Lesbians
    Leucine (amino acid)
    Life Expectancy
    Lipolysis (release of fat from fat cells)
    Liposuction
    Lipozene (see glucomannan)
    Liquid Calories
    Liraglutide
    Longevity
    Lorcaserin (also see Belviq (lorcaserin hydrochloride))
    Low Calorie Diet
    Low Carbohydrate Diets
    Low Fat Diets
    Low Stomach Acid
    Lp(a)
    Ludiomil (maprotiline)
    Luvox (fluvoxamine)
    Magnesium
    Maitake mushroom
    Mammography
    Marijuana (see Cannabis)
    Mark Starr, MD
    Married or Single
    Meal Frequency
    Meal Replacement Shakes
    Measurments of obesity
    Meat, Red
    Mediterranean Diet
    Medium chain triglycerides (MCT's)
    Men, studies about
    Menopause
    Menstruation
    Mercury
    Mercury fillings (Dental amalgams)
    Meridia (sibutramine)
    Metabolic syndrome (also see Insulin Sensitivity)
    Metabolism
    Mifeprex (mifepristone)
    Milk and Dairy
    Mineral aspartates
    Mirapex (pramipexole)
    Mirtazapine (antidepressant Remeron)
    Moban (molindone)
    Monounsaturated fat (Olive Oil and Canola Oil)
    Mortality associated with obesity
    Motivational techniques for losing weight
    Movies
    MSG (monosodium glutamate)
    Multiple Myeloma (See Cancer, Multiple Myeloma)
    Myths, Medical Myths
    N-Acetyl-Cysteine (NAC)
    Naltrexone
    Nasal Blockage
    Nassim Taleb
    Natural Treatments
    Nestatin-1
    Neurontin (gabapentin)
    Niacin (vitamin B3)
    Nicotine
    Night Eating Syndrome
    Night workers/shift workers
    No Dinner Diet
    Nonalcoholic fatty liver disease
    Nortriptyline (See Pamelor)
    Nutrasweet (aspartame)
    Nuts (also see Almonds)
    Obesity Forecasts
    Obesity Guidelines, NIH
    Obesity statistics
    Obesity Statistics, US States
    Obesity, Causes of
    Obesity, Factors associated with
    Oleoyl-estrone
    Olestra
    Olive Oil
    Omega-3 Fatty Acids (fish oil)
    Omega-6 Fatty Acids
    Onions
    Oolong Tea
    Opinion
    Orthomolecular Medicine
    Over-treatment
    Paleo Diet
    Pamelor (nortriptyline)
    Parent's influence on obesity
    Parkinson's Disease
    Paroxetine (antidepressant Paxil)
    PCSK9 inhibitors (cholesterol-lowering drugs)
    Pedometer
    Periactin (cyproheptadine)
    Periodontal Gum Disease
    Personal stories about weigh loss
    Phen-Pro (Phentermine-Prozac or other SSRIs)
    Phendimetrazine (Bontril)
    Phentermine
    Phenylephrine
    Phosphodiesterase type-5 inhibitors, sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra)
    Plastic's effect on body weight
    Plate Size
    Pokeweed extract
    Polar Weight Management Program
    Polio Vaccine (Salk Vaccine)
    Polycystic Ovarian Syndrome
    Polyunsaturated Fat
    Port, Sidney (UCLA statistician)
    Portion size, effect on calore intake
    Post-traumatic stress disorder
    Postnatal weight gain (immediately after birth)
    Postpartum depression
    Potassium
    Pramlintide (see Symlin)
    Predicted Weight Loss
    Pregnancy
    Pregnant women, effects on offspring
    Prejudice against obesity
    Prevalence of Obesity
    Prices for drugs
    Prolixin (fluphenazine)
    Prostate, Enlarged
    Protamine
    Protein (general)
    Protein Leverage Theory
    Protein Source
    Protein supplement
    Protein, High, Diet
    Protein, Low, Diet
    Protein, Soy
    Proton pump inhibitors
    Prozac (fluoxetine)
    PSA Test (Prostate Specific Antigen)
    Psychiatric Drugs
    Pu-erh Tea (Chinese Black Tea)
    Pursuing Weight Control
    Pyruvate
    Qsymia (phentermine and topiramate) (formerly Qnexa)
    Quality of Life
    Radiation (background ionizing radiation)
    Rate of Eating
    Raw food diet
    Red Yeast Rice
    Resistant Starch
    Resveratrol
    Rhodiola rosea (Golden root or Arctic root)
    Rice
    Richard Moore, MD, PhD
    Risperdal (risperidone)
    Ritalin (methylphenidate)
    Robert Skversky, MD
    Robert Whitaker (author & journalist)
    Rubidium
    Saccharin (artificial sweetner)
    Saturated Fat
    Sauna
    Scams
    Schizophrenia
    Seizures
    Self-help weight loss
    Self-reported height and weight
    Self-reported intake
    Serentil (mesoridazine)
    Serlect (sertindole)
    Seroquel (quetiapine)
    Serotonin Syndrome
    Serzone (nefazodone)
    Sex and Sexual Activity
    Sexual abuse
    Shift Workers
    Sick Days
    Simmondsin (jojoba plant seed extract)
    Skinny on Obesity video series
    Sleep
    Sleeping pills
    Smoking's effect on weight
    Snacks
    Snoring
    Social Influence
    Sodium Intake
    Soft drinks (Coke, Pepsi, etc.)
    South Beach Diet
    Splenda (sucralose)
    Spouses
    SSRI's
    Starch Blockers (Amylase inhibitors)
    Statin Nation (documentary)
    Statins
    Stearic Acid (in beef and chocolate)
    Stents (coronary artery stents)
    Strattera (atomoxetine)
    Strength Training
    Stress
    Stroke
    Sugar Addiction
    Sugar intake
    Suicide
    Sumatriptan
    Sun Bathing, Benefits of
    Surmontil (trimipramine)
    Symlin (pramlintide)
    Symlin (pramlintide)
    Sympathetic Nervous Activity (SNS)
    Taranabant
    Taste
    Taubes, Gary
    Taxes and Obesity
    Tea
    Television Watching
    Temperature, House
    Tenuate (See diethylpropion)
    Tesofensine
    Testosterone
    Thermogenesis
    Thermography
    Thiomersal (mercury-containing preservative)
    Thorazine (chlorpromazine)
    Thyroid Function
    Thyroid supplement
    Thyroid, Desiccated
    Timeline related to obesity discoveries
    Tofranil (imipramine)
    Tofu (soybean curd)
    Tonsils
    Too much medicine
    Topamax (topiramate)
    TOPS (Take Off Pounds Sensibly)
    Trans Fats
    Trazedone (antidepressant)
    Tricyclic antidepressants
    Triglyceride levels
    Tryptophan
    Underreporting weight
    Urinary incontinence
    Vaccines
    Vegetable-based Diet
    Vegetables
    Vegetables, Raw
    Vegetarians
    Venlafaxine (antidepressant Effexor)
    Ventricular arrhythmias
    Vertical Banded Gastroplasty
    Very-Low-Calorie Diets
    Vibration, Whole Body
    Vinegar
    Virus and Bacteria associated with obesity
    Virus, obesity (adenovirus-36)
    Visual Cues
    Vitamin C
    Vitamin D
    Vitamins
    Waist measurement
    Waist-to-Hip Ratio
    Wansink, Brian (studies done by)
    Water
    Weighing, Self
    Weight cycling (gaining and losing)
    Weight gain
    Weight Lifting
    Weight Loss Expectations
    Weight Loss Programs
    Weight Loss Strategies
    Weight Loss Success (what successful weight losers do)
    Weight Loss Supplements
    Weight Loss Supplements, Adulterated
    Weight loss surgery
    Weight Loss Surgery - Laparoscopic Sleeve Gastrectomy
    Weight Loss, Benefits of
    Weight loss, Rate of
    Weight loss, risks of
    Weight Maintenance
    Weight monitoring
    Weight Perception
    Weight Watchers
    Weight-gaining drugs
    Wellbutrin (bupropion)
    Wine, Red
    Women, studies about
    Work, Lost Days
    Xenical (orlistat)
    YouTube videos
    Zerona laser
    Zetia (ezetimibe)
    Zinc
    Zocor (simvastatin)
    Zoloft (sertraline)
    Zonegran (zonisamide)
    Zyprexa (olanzapine)

    ARCHIVES

    August, 2017
    July, 2017
    June, 2017
    May, 2017
    April, 2017
    March, 2017
    February, 2017
    January, 2017
    December, 2016
    November, 2016
    October, 2016
    September, 2016

    ARCHIVE SUMMARY

    View by Date
    View by Category

    RSS / XML


    RSS 1.0
    RSS 2.0
    RSS Atom

    WEATHER

    Weather around the country

    QUOTE OF THE DAY

    QUICKLINKS AND VIEW OPITONS

  • Articles with Recent Comments
  • Recent Forum Topics
  • Summary View
  • Headline View
  • Archive of Quotes
  • SUMMARY VIEW

    NEW! Page 1 of 2. Go to page  1 2 > 

    Friday, July 20, 2012

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Paresthesia (tingling in hands, feet, or face,) in 14% to 20% of patients

    Paresthesia (tingling in hands, feet, or face,) occurred in approximately 14% of subjects given the lower doses of Qsymia (7.5 mg phentermine / 46 mg topiramate), and in 20% of patients given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 1:05 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Dry Mouth in 14% to 19% of patients

    Dry Mouth occurred in approximately 14% of subjects given the lower doses of Qsymia (7.5 mg phentermine / 46 mg topiramate), and in 19% of patients given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 1:03 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Constipation in 15% to 16% of patients

    Constipation occurred in approximately 15% of subjects given the lower doses of Qsymia (7.5 mg phentermine / 46 mg topiramate), and in 16% of patients given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 1:00 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Dizziness in 7% to 9% of patients

    Dizziness occurred in approximately 7% of subjects given the lower doses of Qsymia (7.5 mg phentermine / 46 mg topiramate), and in 9% of patients given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 12:50 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Altered taste or bad taste (dysgeusia) in 7% to 9% of patients

    Altered taste or bad taste (dysgeusia) occurred in approximately 7% of subjects given the lower doses of Qsymia (7.5 mg phentermine / 46 mg topiramate), and in 9% of patients given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 12:40 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Cognitive disorders (problems with concentration, memory) in 7.6% of patients

    Cognitive disorders (problems with attention / concentration, memory, and language (word finding)) occurred in 7.6% of subjects given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) versus 1.5% of people given a placebo according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 12:35 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Anxiety in 4% of patients

    Anxiety occurred in approximately 4% of subjects given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) versus 2% of people given a placebo according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 12:30 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Depression in 4% of patients

    Depression occurred in approximately 4% of subjects given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) versus 2% of people given a placebo according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 12:25 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Reduced sense of touch (hypoesthesia) in 4% of patients

    Reduced sense of touch (hypoesthesia) occurred in approximately 4% of subjects given the lower doses of Qsymia (7.5 mg phentermine / 46 mg topiramate), and in 4% of patients given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 12:20 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Irritability in 3% to 4% of patients

    Irritability occurred in approximately 3% of subjects given the lower doses of Qsymia (7.5 mg phentermine / 46 mg topiramate), and in 4% of patients given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 12:10 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Hair loss (alopecia) in 3% to 4% of patients

    Hair loss (alopecia) occurred in approximately 3% of subjects given the lower doses of Qsymia (7.5 mg phentermine / 46 mg topiramate), and in 4% of patients given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 12:05 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Disturbance in attention in 2% to 4% of patients

    Disturbance in attention occurred in approximately 2% of subjects given the lower doses of Qsymia (7.5 mg phentermine / 46 mg topiramate), and in 4% of patients given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 12:00 pm | [0] comments

    QSYMIA (phentermine / topiramate) SIDE EFFECTS

    Qsymia side effects: Low potassium levels (hypokalemia) in 2% to 3% of patients

    Low potassium levels (hypokalemia) occurred in 1.4% of subjects given the lower doses of Qsymia (7.5 mg phentermine / 46 mg topiramate), and in 2.5% of patients given the higher dose of Qsymia (15 mg phentermine / 92 mg topiramate) according to the prescribing information for the drug.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Fri, Jul 20, 2012 11:39 am | [0] comments

    Thursday, July 19, 2012

    QYSEMIA

    Qsymia (phentermine / topiramate) dosage and administration

    ​Here are the dosage and administration instructions for Qsymia (phentermine / topirimate) as shown in the prescribing information.

    In adults with an initial BMI of 30 kg/m2 or greater or 27 kg/m2 or greater when accompanied by weight-related co-morbidities such as hypertension, type 2 diabetes mellitus, or dyslipidemia prescribe Qsymia as follows: 

    • Take Qsymia once daily in the morning with or without food. 
    • Avoid dosing with Qsymia in the evening due to the possibility of insomnia.
    • Start treatment with Qsymia 3.75 mg/23 mg (phentermine 3.75 mg/topiramate 23 mg extended-release) daily for 14 days; after 14 days increase to the recommended dose of Qsymia 7.5 mg/46 mg (phentermine 7.5 mg/topiramate 46 mg extended-release) once daily.
    • Evaluate weight loss after 12 weeks of treatment with Qsymia 7.5 mg/46 mg.
    • If a patient has not lost at least 3% of baseline body weight on Qsymia 7.5 mg/46 mg, discontinue Qsymia or escalate the dose, as it is unlikely that the patient will achieve and sustain clinically meaningful weight loss at the Qsymia 7.5 mg/46 mg dose.
    • To escalate the dose: Increase to Qsymia 11.25 mg/69 mg (phentermine 11.25 mg/topiramate 69 mg extended-release) daily for 14 days; followed by dosing Qsymia 15 mg/92 mg (phentermine
    • 15 mg/topiramate 92 mg extended-release) daily.
    • Evaluate weight loss following dose escalation to Qsymia 15 mg/92 mg after an additional 12 weeks of treatment.
    • If a patient has not lost at least 5% of baseline body weight on Qsymia 15 mg/92 mg, discontinue Qsymia as directed, as it is unlikely that the patient will achieve and sustain clinically meaningful weight loss with continued treatment.
    • Qsymia 3.75 mg/23 mg and Qsymia 11.25 mg/69 mg are for titration purposes only.

    Discontinuing Qsymia

    • Discontinue Qsymia 15 mg/92 mg gradually by taking a dose every other day for at least 1 week prior to stopping treatment altogether, due to the possibility of precipitating a seizure [see Warnings and Precautions.
    Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jul 19, 2012 12:08 pm | [0] comments

    QYSEMIA

    Qsymia (phentermine / topiramate) contraindications

    ​Here are the contraindications for Qsymia (phentermine / topirimate) as shown in the prescribing information.

    • Pregnancy
    • Glaucoma 
    • Hyperthyroidism 
    • During or within 14 days of taking monoamine oxidase inhibitors (MAO inhibitors) 
    • Known hypersensitivity or idiosyncrasy to sympathomimetic amines
    Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jul 19, 2012 12:03 pm | [0] comments

    QYSEMIA

    Qsymia (phentermine / topiramate) warnings and precautions

    Here are the warnings and precautions for Qsymia (phentermine / topirimate) as shown in the prescribing information.

    • Fetal Toxicity: Females of reproductive potential: Obtain negative pregnancy test before treatment and monthly thereafter; use effective contraception. 
    • Qsymia is available through a limited program under a Risk Evaluation and Mitigation Strategy (REMS)
    • Increase in Heart Rate: Monitor heart rate in all patients, especially those with cardiac or cerebrovascular disease.
    • Suicidal Behavior and Ideation: Monitor for depression or suicidal thoughts. Discontinue Qysmia if symptoms develop.
    • Acute Myopia and Secondary Angle Closure Glaucoma: Discontinue Qsymia.
    • Mood and Sleep Disorders: Consider dose reduction or withdrawal for clinically significant or persistent symptoms.
    • Cognitive Impairment: May cause disturbances in attention or  memory. 
    • Caution patients about operating automobiles or hazardous machinery when starting treatment.
    • Metabolic Acidosis: Measure electrolytes before/during treatment 
    • Creatinine: Measure creatinine before/during treatment 
    • Use of Antidiabetic Medications: Weight loss may cause hypoglycemia. 
    • Measure serum glucose before/during treatment 
    Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jul 19, 2012 11:50 am | [0] comments

    QYSEMIA

    Qsymia (phentermine / topiramate) drug interactions

    Here are the potential drug interactions for Qsymia (phentermine / topirimate) as shown in the prescribing information.

    • Oral contraceptives: Altered exposure may cause irregular bleeding but not increased risk of pregnancy. 
    • Advise patients not to discontinue oral contraceptives if spotting occurs.
    • CNS depressants including alcohol: Potentiate CNS depressant effects. 
    • Avoid concomitant use of alcohol
    • Non-potassium sparing diuretics: May potentiate hypokalemia [low potassium].
    • Measure potassium before/during treatment 
    Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jul 19, 2012 11:35 am | [0] comments

    QYSEMIA

    Qsymia (phentermine / topiramate), possibility of Suicidal Behavior and Ideation

    Here is information about Suicidal Behavior and Ideation regarding Qsymia (phentermine / topirimate) as shown in the prescribing information.

    Suicidal Behavior and Ideation

    Antiepileptic drugs (AEDs), including topiramate, a component of Qsymia, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. 

    Patients treated with Qsymia should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior. 

    Discontinue Qsymia in patients who experience suicidal thoughts or behaviors.

    Avoid Qsymia in patients with a history of suicidal attempts or active suicidal ideation.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jul 19, 2012 11:30 am | [0] comments

    QYSEMIA

    Qsymia (phentermine / topiramate), possibility of Myopia (nearsightedness) and Glaucoma

    Here is information about the possibility of Myopia [nearsightedness] and glaucoma with the use of Qsymia (phentermine / topirimate) as shown in the prescribing information.

    Acute Myopia [nearsightedness] and Secondary Angle Closure Glaucoma

    A syndrome consisting of acute myopia [nearsightedness] associated with secondary angle closure glaucoma has been reported in patients treated with topiramate, a component of Qsymia. 

    Symptoms include acute onset of decreased visual acuity and/or ocular pain.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jul 19, 2012 11:19 am | [0] comments

    QYSEMIA

    Qsymia (phentermine / topiramate) can cause anxiety, depression and insomnia

    Here is information about the possibility of anxiety, depression and insomnia with the use of Qsymia (phentermine / topirimate) as shown in the prescribing information.

    Mood and Sleep Disorders

    Qsymia can cause mood disorders, including depression, and anxiety, as well as insomnia. 

    Patients with a history of depression may be at increased risk of recurrent depression or other mood disorders while taking Qsymia. 

    The majority of these mood and sleep disorders resolved spontaneously, or resolved upon discontinuation of dosing [see Adverse Reactions].

    Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jul 19, 2012 11:10 am | [0] comments

    QYSEMIA

    Qsymia (phentermine / topiramate) can cause Cognitive Impairment

    Here is information about the possibility of Cognitive Impairment with the use of Qsymia (phentermine / topirimate) as shown in the prescribing information.

    Cognitive Impairment

    Qsymia can cause cognitive dysfunction (e.g., impairment of concentration/attention, difficulty with memory, and speech or language problems, particularly word-finding difficulties).

    Rapid titration or high initial doses of Qsymia may be associated with higher rates of cognitive events such as attention, memory and language/word-finding difficulties [see Adverse Reactions].

    Since Qsymia has the potential to impair cognitive function, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain Qsymia therapy does not affect them adversely.

    If cognitive dysfunction persists consider dose reduction or withdrawal of Qsymia for symptoms that are moderate to severe, bothersome, or those which fail to resolve with dose reduction. 

    Read the entire article | Email this article
    Posted by Larry Hobbs on Thu, Jul 19, 2012 10:59 am | [0] comments

    Wednesday, July 18, 2012

    QSYMIA (phentermine and topiramate)

    Qsymia (phentermine and topiramate) approved by US FDA on July 17, 2012

    Qsymia (phentermine and topiramate extended-release) was approved as a diet pill by the U.S. Food and Drug Administration on July 17, 2012 to be used in addition to a reduced-calorie diet and exercise for chronic weight management.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jul 18, 2012 4:00 pm | [0] comments

    QSYMIA (phentermine and topiramate)

    Qsymia (phentermine and topiramate) should NOT be used during pregnancy

    Qsymia (phentermine and topiramate extended-release) "must not be used during pregnancy because it can cause harm to a fetus," notes the press release from the U.S. Food and Drug Administration.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jul 18, 2012 3:50 pm | [0] comments

    QSYMIA (phentermine and topiramate)

    Qsymia (7.5 mg phentermine plus 46 mg topiramate) lost 6.7% more than with placebo

    Subjects given the lower doses of Qsymia (7.5 mg phentermine plus 46 mg topiramate extended-release) lost 6.7% of their body weight more than those given a placebo.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jul 18, 2012 3:45 pm | [0] comments

    QSYMIA (phentermine and topiramate)

    Qsymia (15 mg phentermine plus 92 mg topiramate) lost 8.9% more than with placebo

    Subjects given the higher doses of Qsymia (15 mg phentermine plus 92 mg topiramate extended-release) lost 8.9% of their body weight more than those given a placebo.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jul 18, 2012 3:40 pm | [0] comments

    QSYMIA (phentermine and topiramate)

    Those who don’t lose at least 3% in 3 months with Qsymia (phentermine plus topiramate)

    Subjects who don't lose at least 3% of their body weight after 3 months on the lower dose of Qsymia (7.5 mg phentermine plus 46 mg topiramate extended-release) are "unlikely to achieve and sustain weight loss with continued treatment at this dose," notes the press release from the U.S. FDA.

    At this point, it should be evaluated based on weight loss if the drug should be discontinued or if the dose should be increased to the higher dose.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jul 18, 2012 3:30 pm | [0] comments

    QSYMIA (phentermine and topiramate)

    Qsymia (phentermine plus topiramate) must not be used in patients with glaucoma

    Qsymia must not be used in patients with glaucoma notes the press release from the U.S. FDA.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jul 18, 2012 3:20 pm | [0] comments

    QSYMIA (phentermine and topiramate)

    Qsymia (phentermine plus topiramate) must not be used in patients with hyperthyroidism

    Qsymia must not be used in patients with hyperthyroidism notes the press release from the U.S. FDA.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jul 18, 2012 3:10 pm | [0] comments

    QSYMIA (phentermine and topiramate)

    Qsymia (phentermine / topiramate) can increase heart rate; risk of heart attack and stroke not known

    Qsymia (phentermine plus topiramate) "can increase heart rate; this drug’s effect on heart rate in patients at high risk for heart attack or stroke" is not known notes the FDA press release.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jul 18, 2012 2:50 pm | [0] comments

    QSYMIA (phentermine and topiramate)

    Qsymia (phentermine/topiramate) most common side effects: tingling of hands and feet, dizziness, etc

    Qsymia's (phentermine plus topiramate) most common side effects are:

    • tingling of hands and feet (paresthesia)
    • dizziness
    • altered taste sensation
    • insomnia
    • constipation
    • dry mouth

    according to the FDA press release.

    Read the entire article | Email this article
    Posted by Larry Hobbs on Wed, Jul 18, 2012 2:30 pm | [0] comments

    Saturday, November 05, 2011

    PHENTERMINE + TOPAMAX

    3.75 mg of phentermine plus 23 mg of topiramate caused weight loss of 5.1% vs 1.6% with placebo

    Obese men and women given 3.75 mg of controlled-release phentermine plus 23 mg of controlled-release topiramate (Topamax) -- the trade name of this drug combination is Qnexa -- lost an average of 5.1% of body weight after one-year compared to an average weight loss of 1.6% for those given a placebo according to a study from the researchers at the University of Alabama at Birmingham. Read the entire article | Email this article
    Posted by Larry Hobbs on Sat, Nov 05, 2011 1:27 pm | [0] comments

    PHENTERMINE + TOPAMAX

    15 mg of phentermine plus 92 mg of topiramate caused weight loss of 10.9% vs 1.6% with placebo

    Obese men and women given 15 mg of controlled-release phentermine plus 92 mg of controlled-release topiramate (Topamax)—the trade name of this drug combination is Qnexa— lost an average of 10.9% of body weight after one-year compared to an average weight loss of 1.6% for those given a placebo according to a study from the researchers at the University of Alabama at Birmingham. Read the entire article | Email this article
    Posted by Larry Hobbs on Sat, Nov 05, 2011 1:20 pm | [0] comments

    PHENTERMINE + TOPAMAX

    Most common side effects with phentermine plus topiramate: paresthesia, dry mouth, constipation

    The most common side effects in people given controlled-release phentermine plus controlled-release topiramate (Topamax) -- the trade name of this drug combination is Qnexa -- according to a study from the researchers at the University of Alabama at Birmingham, were:
    • paresthesia (tingling or pricking of a person's skin, a feeling of "pins and needles"

    • dry mouth

    • constipation

    • altered taste (dysgeusia), and

    • insomnia.
    Read the entire article | Email this article
    Posted by Larry Hobbs on Sat, Nov 05, 2011 10:24 am | [0] comments

    Tuesday, April 26, 2011

    PHENTERMINE + TOPAMAX

    Depression-related events more common in those given 15 mg phentermine + 92 mg Topamax: 7.3% vs 3.8%

    "Depression-related adverse events (excluding sleep disorders)" occurred in 7.3 percent of patients given 15 mg of phentermine plus 92 mg of Topamax (topiramate) versus 3.8 percent in those given 7.5 mg of phentermine plus 46 mg of Topamax (topiramate) versus 3.8 percent in those given a placeboaccording to a new study from Duke University in Durham, North Carolina, USA.

    It took an average of approximately one-month for these symptoms to occur. Read the entire article | Email this article
    Posted by Larry Hobbs on Tue, Apr 26, 2011 2:33 pm | [0] comments

    PHENTERMINE + TOPAMAX

    Anxiety-related events more common in those given 15 mg phentermine + 92 mg Topamax: 7.7% vs 2.8%

    "Anxiety-related adverse events (including irritability)" occurred in 7.7 percent of patients given 15 mg of phentermine plus 92 mg of Topamax (topiramate) versus 4.9 percent in those given 7.5 mg of phentermine plus 46 mg of Topamax (topiramate) versus 2.8 percent in those given a placeboaccording to a new study from Duke University in Durham, North Carolina, USA.

    It took an average of approximately one-month for these symptoms to occur. Read the entire article | Email this article
    Posted by Larry Hobbs on Tue, Apr 26, 2011 2:20 pm | [0] comments

    PHENTERMINE + TOPAMAX

    Attention problems more common in those given 15 mg phentermine + 92 mg Topamax: 3.5% vs 0.7%

    "Anxiety-related adverse events (including irritability)" occurred in 3.5 percent of patients given 15 mg of phentermine plus 92 mg of Topamax (topiramate) versus 2 percent in those given 7.5 mg of phentermine plus 46 mg of Topamax (topiramate) versus 0.7 percent in those given a placeboaccording to a new study from Duke University in Durham, North Carolina, USA. Read the entire article | Email this article
    Posted by Larry Hobbs on Tue, Apr 26, 2011 2:04 pm | [0] comments

    PHENTERMINE + TOPAMAX

    Kidney stones 5 times more common in those given 15 mg of phentermine plus 92 mg of Topamax

    Kidney stones were 5 times more common in people given 15 mg of phentermine plus 92 mg of Topamax (topiramate) than those given either a placebo or 7.5 mg of phentermine plus 46 mg of Topamax (topiramate) according to a new study from Duke University in Durham, North Carolina, USA. Read the entire article | Email this article
    Posted by Larry Hobbs on Tue, Apr 26, 2011 11:03 am | [0] comments

    Monday, April 25, 2011

    PHENTERMINE + TOPAMAX

    7.5 mg of phentermine plus 46 mg of Topamax caused weight loss of 17.8 lbs vs 3.1 lbs with placebo

    People given 7.5 mg of phentermine plus 46 mg of Topamax (topiramate) lost an average of 17.8 pounds in one year versus a weight loss of 3.1 pounds in those given a placebo according to a new study from Duke University in Durham, North Carolina, USA.

    The weight loss represented 7.8 percent of body weight for the drug group versus 1.2 percent for the placebo group. Read the entire article | Email this article
    Posted by Larry Hobbs on Mon, Apr 25, 2011 11:02 am | [0] comments

    PHENTERMINE + TOPAMAX

    15 mg of phentermine plus 92 mg of Topamax caused weight loss of 22.4 lbs vs 3.1 lbs with placebo

    People given 15 mg of phentermine plus 92 mg of Topamax (topiramate) lost an average of 22.4 pounds in one year versus a weight loss of 3.1 pounds in those given a placebo according to a new study from Duke University in Durham, North Carolina, USA.

    The weight loss represented 9.8 percent of body weight for the drug group versus 1.2 percent for the placebo group.

    Note: This is the average weight loss for people regardless of whether they completed the one-year study or if they dropped out early. Read the entire article | Email this article
    Posted by Larry Hobbs on Mon, Apr 25, 2011 10:46 am | [0] comments

    PHENTERMINE + TOPAMAX

    Most common side effects of phentermine plus Topamax were paraesthesia, dry mouth, constipation

    The most common adverse events in people given phentermine plus Topamax (topiramate) were as follows.

    The percentages shown are for those give 15 mg of phentermine plus 92 mg of Topamax (topiramate) versus those give 7.5 mg of phentermine plus 46 mg of Topamax (topiramate) versus placebo.
    • Paraesthesia (tingling, pricking, or numbness of the skin) in 21% vs 14% vs 2%

    • Dry Mouth in 21% vs 13% vs 2%

    • Constipation in 17% vs 6% vs 5%

    • Insomnia in 10% vs 7% vs 3%

    • Dizziness in 10% vs 7% vs 3%

    • Dysgeusia (altered taste) in 10% vs 7% vs 1%
    Read the entire article | Email this article
    Posted by Larry Hobbs on Mon, Apr 25, 2011 10:31 am | [0] comments
    NEW! Page 1 of 2. Go to page  1 2 > 

    © Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.

    Articles with Recent Comments from Readers
    (Click here to see a complete list)
  • Qnexa side effects (phentermine plus Topamax): 20% paresthesia, 18% dry mouth, 15% altered taste

  • Qnexa: Phentermine-Topriamate drug combo causes half of patients to lose an average of 25 pounds

  • 43-year-old man loses 44 lbs in 3 months on phentermine plus Topamax (topiramate)

  • Qsymia side effects: Paresthesia (tingling in hands, feet, or face,) in 14% to 20% of patients

  • Qsymia side effects: Dry Mouth in 14% to 19% of patients

  • Qsymia side effects: Constipation in 15% to 16% of patients

  • Qsymia side effects: Dizziness in 7% to 9% of patients

  • Qsymia side effects: Altered taste or bad taste (dysgeusia) in 7% to 9% of patients

  • Qsymia side effects: Cognitive disorders (problems with concentration, memory) in 7.6% of patients

  • Qsymia side effects: Anxiety in 4% of patients

  • Qsymia side effects: Depression in 4% of patients

  • Qsymia side effects: Reduced sense of touch (hypoesthesia) in 4% of patients

  • Qsymia side effects: Irritability in 3% to 4% of patients

  • Qsymia side effects: Hair loss (alopecia) in 3% to 4% of patients

  • Qsymia side effects: Disturbance in attention in 2% to 4% of patients

  • Qsymia side effects: Low potassium levels (hypokalemia) in 2% to 3% of patients

  • Qsymia (phentermine / topiramate) dosage and administration

  • Qsymia (phentermine / topiramate) contraindications

  • Qsymia (phentermine / topiramate) warnings and precautions

  • Qsymia (phentermine / topiramate) drug interactions

  • Qsymia (phentermine / topiramate), possibility of Suicidal Behavior and Ideation

  • Qsymia (phentermine / topiramate), possibility of Myopia (nearsightedness) and Glaucoma

  • Qsymia (phentermine / topiramate) can cause anxiety, depression and insomnia

  • Qsymia (phentermine / topiramate) can cause Cognitive Impairment

  • Qsymia (phentermine and topiramate) approved by US FDA on July 17, 2012

  • Qsymia (phentermine and topiramate) should NOT be used during pregnancy

  • Qsymia (7.5 mg phentermine plus 46 mg topiramate) lost 6.7% more than with placebo

  • Qsymia (15 mg phentermine plus 92 mg topiramate) lost 8.9% more than with placebo

  • Those who don’t lose at least 3% in 3 months with Qsymia (phentermine plus topiramate)

  • Qsymia (phentermine plus topiramate) must not be used in patients with glaucoma

  •  
    Recent Forum Topics

    (Please share your comments & experience)
  • Welcome!
    07/03/2013 07:22 pm

  • Acomplia - what is your personal opinion?
    02/15/2013 02:42 pm

  • The different components of weight and how they vary over time
    07/04/2012 05:54 pm

  • How weight varies as we sleep
    07/04/2012 05:48 pm

  • Beer
    06/15/2012 12:42 am

  • Wellbutrin, Topamax and Phentermine
    05/16/2012 04:00 pm

  • Want to Take Phen-Pro
    03/13/2012 09:07 pm

  • I recently got a prescription for phentermine
    12/30/2011 12:20 pm

  • Topamax plus Wellbutrin = no appetite
    12/26/2011 04:59 pm

  • Thinking of doing Dr. Joan Mathews Larson’s Health Recovery Center
    12/06/2011 07:02 pm

  • Phentermine
    07/23/2011 09:11 am

  • Phentermine and Nicotine
    07/15/2011 12:02 am

  • In there any conflict taking ephedra with 5-HTP
    05/08/2011 03:55 pm

  • 7-keto lessens carb cravings?
    05/05/2011 04:45 pm

  • Does Requip (ropinirole) cause weight gain?
    04/20/2011 08:46 pm

  • The Acai Berry Hoax??
    01/31/2011 07:47 am

  • Phentermine and Heart Rate
    12/22/2010 09:30 pm

  • Long Time on Phentermine
    07/05/2010 07:43 am

  • Main Site Link and Howdy
    01/28/2010 02:08 pm

  • Modafinil and Adrafinil
    01/17/2010 07:30 am

  • How should i use EAS Betagen?
    12/13/2009 09:15 am

  • Is it suitable?
    12/12/2009 11:56 am

  • Ephedrine and caffeine - Still quite popular among bodybuilders cutting fat
    11/13/2009 05:19 pm

  • Phenobarbital and Elsinore Pill
    11/09/2009 08:24 pm

  • Methylephedrine and Pseudoephedrine
    11/09/2009 10:57 am

  • 262,000 Calories and Hopelessness
    11/04/2009 07:43 pm

  • Has anyone used DEX-C20? (new herbal diet pill made of Caralluma Fimbriata)
    10/19/2009 11:41 am

  • Correct dosage?
    09/08/2009 11:24 am

  • General Tips for Fast Weight Loss
    07/10/2009 09:26 am

  • Arginine is working
    06/24/2009 11:27 am

  •